It was amateur hour and complete stuff up from those in charge. FDA wanted to fast track approval as they had a conga line of interested third parties who lobbied on their behalf. They had raised all these funds from a CR to finance FDA approval. How they spent these funds is anyone's guess, but they made an absolute meal out of it and lost all momentum let alone good will from those third parties who went in to bat for them. So here we are at the back of the queue waiting to get back in. Meanwhile in la la land, the remuneration report gets the go ahead whilst the shareholders watch as the value in their investment goes out the door. James McBrayer take a bow!!
CYC Price at posting:
$1.00 Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)